Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Tetralogy of Fallot
Patricia OBrien, MSN, CPNP-AC; Audrey C. Marshall, MD
What Is TOF?
TOF is a defect combining 4 abnormalities that are all related (Figure):
1. Right ventricular outflow tract
obstruction. The connection
between the right ventricle of the
heart and the lungs is narrowed,
and the blood flow to the lungs
is reduced. The main area of narrowing is under the pulmonary
valve, caused by thick muscle in
this area. The valve may also be
narrow (stenotic), and the pulmonary artery may also be small
(hypoplastic).
The information contained in this Circulation Cardiology Patient Page is not a substitute for medical advice, and the American Heart Association
recommends consultation with your doctor or healthcare professional.
From the Department of Nursing/Patient Services, Cardiovascular Program, Boston Childrens Hospital, Boston, MA (P.O.); and Department of Pediatrics,
Harvard Medical School, and Cardiac Catheterization Laboratory, Department of Cardiology, Boston Childrens Hospital, Boston, MA (A.C.M.).
Correspondence to Patricia OBrien, MSN, CPNP-AC, Department of Nursing/Patient Services, Cardiovascular Program, Boston Childrens Hospital.
E-mail pat.obrien@cardio.chboston.org
(Circulation. 2014;130:e26-e29.)
2014 American Heart Association, Inc.
Circulation is available at http://circ.ahajournals.org
DOI: 10.1161/CIRCULATIONAHA.113.005547
e26
Figure. Diagram of normal heart contrasted with heart defects associated with Tetralogy of Fallot. From Boston Childrens Hospital Web site.
Hypercyanotic Spells
Infants with TOF may have hypercyanotic spells (Tet spells), episodes in
Characteristics
Treatments
Newborn
TEMPORARY PROCEDURES:
SURGERY: Shunt procedure: Gore-Tex tube from an artery off the
aorta to the pulmonary artery to provide blood flow to the lungs
CATHETERIZATION: dilation of the pulmonary valve
36 mo
Surgical Treatment
Most infants have a surgical repair at
3 to 6 months of age. Surgery is done
through an incision in the center of the
chest along the sternum (breastbone),
and the heart-lung bypass machine is
used to support the circulation during
the operation (Table1). Infants are usually in the hospital for about a week and
fully recover in 4 to 6 weeks. Surgical
results are excellent, with a less than
2% surgical mortality and very good
long-term outcomes.
After surgery, infants are in the
intensive care unit for several days, are
on a ventilator to help them breathe,
and receive medicines to help the heart
recover from surgery. A problem seen
early after surgery can be fluid overload in the lungs and body because the
right ventricle is not pumping effectively as it recovers. Medicines called
diuretics are used to help get rid of
extra fluid. Problems with abnormal
heartbeats (rhythm problems) may also
occur after surgery because of swelling
or injury to the electric system of the
heart, which runs next to the ventricular septal defect. Rarely, a pacemaker
may be needed if the rhythm does not
return to normal.
Long-Term Concerns
During childhood, most children do
very well, with normal growth and
development, but need regular cardiology care (Table2). However, even
successful surgery does not result in
a totally normal heart. The right ventricular outflow tract often has some
degree of obstruction, and the pulmonary valve does not function normally.
As a result of most surgical repairs, the
valve leaflets cannot close completely,
allowing blood to leak back into the
right ventricle (called pulmonary
regurgitation).
Summary
TOF is a congenital heart defect that
results in decreased blood flow to the
lungs and is successfully repaired
by surgery in infancy, allowing most
patients a normal lifestyle. Lifelong
follow-up is important to watch for
problems such as an abnormal heart
rhythm, leaking of the pulmonary
valve, or poor function of the right
ventricle. Continued research leading
to new knowledge and treatments for
congenital heart disease will improve
the care of children in the future.
Disclosures
None.
Additional Resources
Marino BS, Lipkin PH, Newburger JW, Peacock G,
Gerdes M, Gaynor JW, Mussatto KA, Uzark
K, Goldberg CS, Johnson WH, Li J, Smith SE,
Bellinger DC, Mahle WT. Neurodevelopmental
outcomes in children with congenital heart disease: evaluation and management: Scientific
Statement from the American Heart Association.
Circulation. 2012;126:11431172.